Back to state act
Description
On 3 June 2024, the Biomedical Advanced Research and Development Authority (BARDA) provided USD 33.8 million in funding to CastleVax to develop their NDV-HXP-S vaccine, which uses a Newcastle disease ...
Sign in to see full description
Intervention Details
Intervention Type
State aid, unspecified
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
03 Jun 2024
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 1 products
Threads
See all
This intervention is not part of any Thread yet.